| Literature DB >> 25880528 |
Xiaoqin Yu1, Chao Zhang2, Liping Yang3, Lamei Zhao4, Chun Lin5, Zhengjie Liu6, Zichao Mao7,8.
Abstract
BACKGROUND: Agrobacterium sp. ATCC31749 is an efficient curdlan producer at low pH and under nitrogen starvation. The helix-turn-helix transcriptional regulatory protein (crdR) essential for curdlan production has been analyzed, but whether crdR directly acts to cause expression of the curdlan biosynthesis operon (crdASC) is uncertain. To elucidate the molecular function of crdR in curdlan biosynthesis, we constructed a crdR knockout mutant along with pBQcrdR and pBQNcrdR vectors with crdR expression driven by a T5 promoter and crdR native promoter, respectively. Also, we constructed a pAG with the green fluorescent protein (GFP) gene driven by a curdlan biosynthetic operon promoter (crdP) to measure the effects of crdR expression on curdlan biosynthesis.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25880528 PMCID: PMC4327974 DOI: 10.1186/s12866-015-0356-1
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Bacterial strains and plasmids used in this study
|
|
|
|
|---|---|---|
| Strains | ||
|
|
| Lab stock |
|
| Cloning host | TaKaRa |
| ATCC31749 | Curdlan-producing | ATCC |
| ATCC31749Δ | ATCC 31749 mutant with gene knockout of | This study |
|
| ||
| pEGFP | GFP expression vector | Clontech |
| pQE81L | Expression vector, | Qiagen |
| pBBR122 | Gram-negative broad host vector | MoBiTec |
| pEX18Gm | Expression vector carrying | [ |
| pBQ | Vector derived from both pQE80 and pBBR122 | [ |
| pUC19 | Cloning vector | TaKaRa |
| pUC19T-crdR | Suicide vector for | This study |
| pBQcrdR | Expression vector with | This study |
| pBQNcrdR | Expression vector with | This study |
| pAG | Expression vector with | This study |
| pMD18-T( | Derivative of pMD18-T with part of | This study |
| pMD18-T | Derivative of pMD18-T with part of | This study |
| pMD18-T( | Derivative of pMD18-T with part of | This study |
| pMD18-T( | Derivative of pMD18-T with part of | This study |
Primers used in this study
|
|
|
|
|
|---|---|---|---|
|
| GTACTCGAGATTGTCGGCAGTCCAG | 607 |
|
|
| AGCTCCTCGCCCTTGCTCACCATGAAATCAACTCCTCTGT | ||
| GFP-1 | ACAGAGGAGTTGATTTCATGGTGAGCAAGGGCGAGGAGCT | 746 |
|
| GFP-2 | CGCGGATCCTTACTTGTACAGCTCGTCCATG |
| |
| crdP-1 | TCACCAACACCAACTCTGGA | ||
| crdP-2 | CATGAAATCAACTCCTCTGT | 607 |
|
| crdP142-1 | ATCGTCAGATGCCTATTTGT | 537 |
|
| crdP108-1 | AAATTAGTTAATGCAAT | 503 |
|
|
| TTAATGCAATTTTTACTATGTT | 493 |
|
|
| CCATTTCAATACTGCGGGAGG | 448 |
|
|
| AGGAGTTGATTTCATGCTGTT | 408 |
|
|
| ATGCTGTTCCGCAATAAG | 395 |
|
|
| TCGGTCCGCAGCAGCAAAG | ||
|
| CAAGGCATAAGCGAAGACATC | 227 |
|
|
| CTCCGTGTTTCAAGTGTGGTC | ||
|
| AACCTGACGATTGCGATTGGG | 179 |
|
|
| GTGTAGCACCAGAGCGTTTCG | ||
|
| GTTCGGTCAGGATGCTCAAC | 248 |
|
|
| GCCAAAGTTCGGAATCAATG | ||
|
| GCCAGATCTATGACCGAGAATAAGAAAAAGCCT | 437 |
|
|
| TTGAGCTCTTACTCGGCGTCGCCTTCG | ||
|
| ACACTCGAGATACACCCGGTCCCTACCAGCATT |
| |
|
| TTTGAGCTCCTTGTCCTTCTTCAGAAGCGTGT | 1302 |
|
|
| TCGGAATGAGCCAGGAGAAGC | 238 |
|
|
| TCAGCCGAGGACAGAAAGTCG | ||
|
| TCTGAGCTCTTCGGCGTTTCGGAATGGTTG | 2533 |
|
|
| CAACACAAGCTTAACCGTCACCTGGCTCTTGGCA | ||
|
| TTGGGCATACGGGAAGAAGT | 558 |
|
|
| CGGCTGATGTTGGGAGTAGG | 577 | |
| Rep-Kan-1 | ACGCGTCGACCTTGCCAGCCCGTGGATAT | 3266 |
|
| Rep-Kan-2 | ACGCGTCGACTCTGTGATGGCTTCCATGTC | ||
| Gm-1 | ATAGTTGTCGAGATATTCACTAGTCGTCAGGTGGCACTTTTCG | 1302 |
|
| Gm-2 | CGCGGATCCGCTCTGCTGAAGCCAGTTAC | ||
| celAP1 | ACCCGGTCTATCCCATGA | ||
| celAP-2 | CATCCAGAAACTTTCCGT | 441 |
|
| relAP-1 | CCAGATTTCTCAAGGGTC | ||
| RelAP-2 | CATCATGCGATATTCCACA | 443 |
|
| crdRP-1 | GCGGCGATCCTAAATGTGAC | ||
| crdRP-2 | CATGCGGTCCTGACACTCG | 466 |
|
| crdSP-1 | TCGGTCGGCACATGGGTCAAT | ||
| crdSP-2 | CATCGCCCTAACCTCGCAGT | 446 |
|
Figure 1Maps of pUC19T-crdR (A) and pBQNcrdR (B).
Figure 2Confirmation of the ATCC31749 mutant by PCR amplification. (A, B) crdR was replaced without and with gentamicin resistance gene (Gm) in ATCC31749; (C) PCR amplification. CM: 2Kb DNA ladder, C1, C3, C5: template of genomic DNA of wild-type ATCC31749, while C2, C4, C6: template of genomic DNA of ATCC31749ΔcrdR candidate were used respectively. C2: amplification of the Gm gene; C4: amplification of a fused fragment of the crdR upstream flanking region and the 5’-end of the Gm gene; C6: amplification of the fused fragment of 3’-end of the Gm and the crdR downstream flanking region.
Figure 3Effects of on morphological changes. (A, B, C) ATCC31749, ATCC317ΔcrdR/pBQNcrdR and ATCC317ΔcrdR cultivated in growth medium, (D, E, F) ATCC31749, ATCC317ΔcrdR/pBQNcrdR, and ATCC317ΔcrdR cultivated in curdlan-producing medium.
Figure 4Changes in curdlan yields (A) and cell biomasses (B) of different strains. Data are means of 3 independent measurements; vertical bars indicate standard errors.
The expressions of the genes quantified by q-RT-PCR*
|
|
|
|
| |
|---|---|---|---|---|
|
| 0.2373 ± 0.0635 | 1.0944 ± 0.0956 | 244.2038 ± 18.3645 | 923.5690 ± 29.6543 |
|
| 0.4050 ± 0.1022 | 2.7739 ± 0.1185 | 86.7645 ± 4.2966 | 176.6229 ± 9.5607 |
|
| 0.4972 ± 0.9503 | 2.2787 ± 0.1263 | 4.5239 ± 0.3371 | 14.5744 ± 1.0027 |
|
| 14.9112 ± 1.0359 | 654.8556 ± 20.4256 | 29.2068 ± 1.8553 | 193.1226 ± 11.2094 |
*The data are means of three independent determinations, and the unite of value is copies per ng total RNA(copies/ng RNA) E: strain in exponential phase, S:strain in stationary phase.
Figure 5expressions in constructed strains. (A, B) Stationary phase ATCC31749ΔcrdR/pAG and ATCC31749/pAG observed with fluorescent Microscopy; (C, D) Stationary phase ATCC31749ΔcrdR/pAG and ATCC31749/pAG observed with bright-field microscopy; (E) relative emissive fluorescence of strains activated by light (395 nm); (E1, E2) ATCC31749/pAG and ATCC31749ΔcrdR/pAG at exponential phase; (E3, E4) ATCC31749/pAG and ATCC31749ΔcrdR/pAG at stationary phase. Data are means of 3 independent measurements; vertical bars indicted standard errors.
Figure 6Binding ability of 6 His-tagged crdR to different DNA fragments. A: Different region of the crdP; B: purification of 6 His-tagged crdR; C, D: Binding ability 6 His-tagged crdR to different regions of crdP; E: Binding of 6 His-tagged crdR, to ~450 bp upstream of ATG at different gene coding regions. BM: protein markers, B1: purified His-tagged crdR, B2: supernatant of pBQcrdR/E. coli Bl21; C1. C4, C7, and C10 are 10 μL of 0.5 μM crdP 98, crdP102, crdP142 and crdP mixed with 10 L of 0.5 mg/mL purified 6 His-tagged crdR protein respectively, C2, C5, C8, and C11 are same as C1. C4, C7, and C10, except 6 His-tagged crdR protein was reduced to 0.25 mg/mL; C3, C8, C9, and C12 are same as C1. C4, C7, and C10, without 6 His-tagged crdR. D1. D4, D7, and D10 are 10 μL of 0.5 μM crdP 98, crdP53, crdP13, and crdP1 only respectively, D2, D5, D8, and D11 are same of .D1. D4, D7, and D10 mixed with 10 μL 0.5 mg/mL 6 His-tagged crdR protein; D3, D8, D9, and D12 are same of .D1, D4, D7, and D10 mixed with 10 μL 0.5 mg/mL BSA respectively, E1, E4, E7, and E10 are crdRP, celAP, and crdSP, E2, E5, E8, and E11 are same of E1, E4, E7, and E10 mixed with 10 μL of 0.25 mg/mL 6 His-tagged crdR protein respectively, E3, E6, E9, and E12 are same of E1, E4, E7, and E10 mixed with 10 μL of 0.5 mg/mL BSA respectively.